ProShares Ultra Nasdaq Biotechnology
ProShare Advisors LLC BIB ETF
| BIB Price | $51.5759 |
Market Cap | $68.11M |
| Annual Dividend Yield | 0.89% |
Annual Dividend | $0.50 |
| Yearly Management Fee | 0.95% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Pharma, biotech & life sciences |
Last 24h Volume | $15.25K |
| Portfolio Management Company | ProShare Advisors LLC |
Discount/Premium to NAV | -0.07% |
| Inception Date | Apr 07, 2010 |
Market Cap Rank | 2257 |
| Monthly AUM Growth | -3.74% |
Holdings Region | North America |
| Management Style | Passive |
Leverage | Leveraged 2x |
ProShares Ultra Nasdaq Biotechnology is an ETF issued by ProShare Advisors LLC on Apr 07 2010.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of BIB ETF according to its net asset value is discounted at -0.07%.
While the total value of the fund shows $-2,645,620 decrease compared to the previous month, its price is traded daily at a decrease of -7.54%.
The annual dividend yield of BIB ETF is 0.89%, whereas its main asset area is North America.
BIB ETF, whose 24-hour total volume is $15.25K, has experienced a $-5,798,684 cash outflow in the last month.
In addition, ProShares Ultra Nasdaq Biotechnology's one-year net asset value total return is 3.88%.
BIB ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| -7.54% |
-10.47% |
-3.88% |
-24.26% |
-12.23% |
-8.33% |
-3.65% |
BIB ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| 4.66% |
-17.86% |
-1.49% |
3.88% |
-31.99% |
-9.67% |
BIB ETF Comments
no comments yet